Mode
Text Size
Log in / Sign up

Papillary Thyroid Carcinoma

Part of Head and Neck Cancer

13 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials for Papillary Thyroid Carcinoma

2 trials tracked for Papillary Thyroid Carcinoma.

2Trials tracked
0Phase 3 & 4
0Recruiting
0With published results
  1. N/A Comparison Between the Axillary Bilateral-breast Approach (ABBA) and Bilateral Axillo-breast Approach (BABA) for Robotic Thyroidectomy Completed
  2. N/A Re-differentiation of Radioiodine-Refractory BRAF V600E-mutant Papillary Thyroid Carcinoma With GSK2118436 Completed

Showing the 2 most-cited and recently-updated of 2 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.

Research across Head and Neck Cancer

Related studies from across the Head and Neck Cancer family.

miR-155 overexpression is frequently associated with treatment resistance across 8 cancer types
Drug Pipeline Meta-analysis
miR-155 overexpression is frequently associated with treatment resistance across 8 cancer types miR-155 Expression Linked to Treatment Resistance in Various Cancers
This systematic review of 19 studies across 8 cancer types indicates that miR-155 overexpression is associated with treatment resistance in …
Research suggests that high levels of a specific molecule, miR-155, may be linked to how well certain cancers respond to treatment.
Molecular testing reduces surgical resection rates for indeterminate thyroid nodules in Western and Asian cohorts
Oncology Meta-analysis
Molecular testing reduces surgical resection rates for indeterminate thyroid nodules in Western and Asian cohorts Molecular testing helps decide if surgery is needed for thyroid nodules
This meta-analysis of 127 studies evaluated the impact of molecular testing on surgical management and risk of malignancy for indeterminate …
Molecular testing can help doctors decide if surgery is necessary for thyroid nodules, showing different clinical roles in Western and Asian…
Vitamin D and gut microbiota interact to regulate immunity and improve bioavailability in thyroid disorders
Diabetes & Endocrinology Sys. Review
Vitamin D and gut microbiota interact to regulate immunity and improve bioavailability in thyroid disorders Vitamin D and gut health may help manage thyroid disorders
This systematic review explores the interplay between Vitamin D and gut microbiota in patients with thyroid disorders, including autoimmune …
New research highlights how vitamin D and gut bacteria work together to support the immune system in people with thyroid conditions.
Gut Microbiome and Metabolites May Modulate Thyroid Cancer Immunity and Treatment Response
Oncology Sys. Review
Gut Microbiome and Metabolites May Modulate Thyroid Cancer Immunity and Treatment Response Gut bacteria and metabolites may influence thyroid cancer treatment
This narrative review examines how gut dysbiosis, bacterial outer membrane components such as lipopolysaccharides, and metabolites including…
Your gut health might play a hidden role in how your body responds to thyroid cancer treatments and immune system interactions.
CEUS combined with AI or elastography improves diagnostic performance for malignant thyroid nodules
Diabetes & Endocrinology Meta-analysis
CEUS combined with AI or elastography improves diagnostic performance for malignant thyroid nodules Contrast-Enhanced Ultrasound Shows Promise for Identifying Thyroid Nodules
This network meta-analysis of 5022 thyroid nodules evaluated the diagnostic performance of contrast-enhanced ultrasound (CEUS) combined with…
New analysis shows that combining contrast-enhanced ultrasound with other imaging tools can help doctors better identify malignant thyroid n…
Hashimoto's thyroiditis is a risk factor for papillary thyroid cancer with associated improved outcomes
Diabetes & Endocrinology Sys. Review
Hashimoto's thyroiditis is a risk factor for papillary thyroid cancer with associated improved outcomes Hashimoto's thyroiditis linked to both cancer risk and better outcomes
This narrative review examines the relationship between Hashimoto's thyroiditis (HT) and papillary thyroid cancer (PTC). The authors suggest…
A growing body of evidence shows that while Hashimoto's thyroiditis can increase cancer risk, it may also be linked to better outcomes for p…
Sociodemographic, laboratory, and ultrasonographic factors are associated with malignancy risk in thyroid nodules
Diabetes & Endocrinology Meta-analysis
Sociodemographic, laboratory, and ultrasonographic factors are associated with malignancy risk in thyroid nodules Specific Factors Linked to Higher Risk in Thyroid Nodules
This systematic review and meta-analysis of 194 studies evaluated sociodemographic, laboratory, and ultrasound features to assess malignancy…
Certain factors like male sex and specific ultrasound features are linked to a higher risk of cancer in patients with thyroid nodules.
Intraoperative frozen section shows 98.8% specificity but limited sensitivity for detecting malignancy in Bethesda III nodules
ENT (Otolaryngology) Sys. Review
Intraoperative frozen section shows 98.8% specificity but limited sensitivity for detecting malignancy in Bethesda III nodules Frozen Section Analysis Shows High Specificity for Thyroid Nodules
This systematic review and meta-analysis of 1,069 patients with thyroid nodules evaluates the diagnostic accuracy of intraoperative frozen s…
Intraoperative frozen section tests show high accuracy in identifying cancer in certain thyroid nodules, but results can vary significantly.
Contrast-enhanced ultrasound shows 81.6% diagnostic accuracy for differentiating benign from malignant thyroid nodules
Diabetes & Endocrinology Meta-analysis
Contrast-enhanced ultrasound shows 81.6% diagnostic accuracy for differentiating benign from malignant thyroid nodules Contrast-enhanced ultrasound shows promise for thyroid nodule diagnosis
This meta-analysis of 54 CEUS studies evaluated the diagnostic performance of contrast-enhanced ultrasound for characterizing thyroid nodule…
A new analysis finds contrast-enhanced ultrasound is 78.6% sensitive and 82.6% specific for telling benign from malignant thyroid nodules.
Case report review highlights suspicion of breast cancer metastasis to thyroid in a 54-year-old woman
Orthopedics & Sports Medicine Sys. Review
Case report review highlights suspicion of breast cancer metastasis to thyroid in a 54-year-old woman Breast cancer can spread to the thyroid gland in rare cases
This case report review describes a 54-year-old woman with a history of breast cancer who developed metastasis to the thyroid. The authors n…
A single case report shows a 54-year-old woman survived after breast cancer spread to her thyroid, highlighting the need for careful diagnos…
Review of 32 cases of thyroid hemiagenesis with carcinoma highlights surgical and diagnostic patterns
Diabetes & Endocrinology Sys. Review
Review of 32 cases of thyroid hemiagenesis with carcinoma highlights surgical and diagnostic patterns Doctors found rare thyroid cancer cases in patients with one missing half of their gland
This review and case series of 32 patients with thyroid hemiagenesis complicated by thyroid carcinoma synthesized diagnostic and treatment p…
A review of thirty-two patients shows that having half a thyroid gland does not stop cancer from forming. Most cases were treated with surge…
TIRADS and Bethesda systems predict thyroid malignancy in 70 patients at Baghdad Teaching Hospital
Radiology & Imaging Cohort
TIRADS and Bethesda systems predict thyroid malignancy in 70 patients at Baghdad Teaching Hospital Family history and neck swelling signal higher risk of thyroid cancer
This prospective cross-sectional study evaluated 70 patients with thyroid complaints at Baghdad Teaching Hospital.
A new look at thyroid nodules shows that family history and neck swelling are key signs of cancer, helping doctors catch it sooner.

Questions about Papillary Thyroid Carcinoma

Does finding a BRAFV600E mutation mean I have papillary thyroid carcinoma when my cytology results were non-malignant?

No, a BRAFV600E mutation alone does not confirm papillary thyroid carcinoma if your cytology was non-malignant; it raises suspicion but requires surgical pathology for a definitive diagnosis.

Full answer →
How can a nomogram model using my age and ultrasound features help distinguish my papillary thyroid carcinoma from benign nodules?

A nomogram model combines your age, ultrasound features (like tumor size and microcalcifications), and sometimes blood markers to estimate the chance that a thyroid nodule is papillary thyroid carcinoma rather than benign.

Full answer →
Can a machine learning model predict if I have lymph node metastasis in my papillary thyroid carcinoma?

Yes, several machine learning models can predict lymph node metastasis in papillary thyroid carcinoma with good accuracy, using clinical, imaging, and genetic data.

Full answer →

All Papillary Thyroid Carcinoma Articles